chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt recv vax 10dec96;concomitant vax included hep B vax, recombinant; concomitant therapy included meds; pt was recv the PPD skin test 13dec96 & 30dec96; 01jan97 the pt devel shingles on the left interior buttocks; looked like small papules
fever and chills on 20th about 4 hours after vaccine. On 21st i felt like i had the full blown reactions like I had the virus again. which i was positive for on Dec 4 2020.  Headache dizziness, fever,  chills diarrhea. bones aching and neck pain,  on the 22nd i started feel better but not well. And then by the 23rd i still had the lingering headache and dizziness, and neck pain but all other symptoms are gone.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date'; Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date'; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date') and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date') in a 27-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 066H21A) for COVID-19 vaccination.     Acute illness at the time of vaccination and up to one month before was reported as unknown. Chronic or long-standing health conditions was reported as unknown.     On 16-Feb-2022 at 9:06 AM, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) .5 milliliter. On 16-Feb-2022 at 9:06 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date'). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date'). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date') and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 'vaccine administration date') outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Prescriptions, over the counter medications, dietary supplements or herbal remedies being taken at time of vaccination  or at the time of the adverse event were reported as unknown. Other vaccines given on the same day as Moderna COVID-19 vaccine and other vaccines received within one month prior to any dose of Moderna COVID-19 vaccine were reported as unknown. It was reported that on 16-Feb-2022 at 09:06:37, the patient received first dose. Vaccine went into 2-8 C thaw state on or about 24-Dec-2021. No treatment information was reported.   This case was linked to MOD-2022-542869 (Patient Link).
8/9/13 - presents with tingling around lips, rash neck (L) side of face with itching -> BENADRYL, DECADRON - later that evening seen in ER increased in P, hives. Rx PEPCID IV and SOLUMEDROL - returned to ER 8/10 with similar sx - PEPCID IV - 8/13 - improving.
After pt received MENVEO, pt became diaphoretic & lightheaded. Pt did well after 20 min. Pt became pale, diaphoretic & dizzy after immunization. Pt told lay on table BP 96/60 HR 71 Ox 99%. Waited 20 min & BP 102/62.
Chills; Right eye was swollen; This is a spontaneous report from a contactable consumer (patient).  A 61-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration on 05Jan2021 at single dose for COVID-19 immunization. The patient medical history included ongoing diabetes and blood pressure high from an unknown date and unknown if ongoing.  The patient's concomitant medication included metformin at 500 mg for diabetes. On 06Jan2021, the patient experienced chills and right eye was swollen. The patient outcome of chills was recovered and the outcome of "right eye was swollen" was not recovered.
Patient presented to the pharmacy today with soft tissue swelling below the armpit area next to the chest wall with a slight pink tone to skin.  No fever, drainage, hardness, or tenderness at injection site.  The patient received the injection 4 days ago.
Client reported to RN at 1800 feeling itchiness on bilateral arms and chest, and slight lightheadedness.  Upon arrival client sitting upright in chair, alert and oriented x4. Per client was about to complete 30 min observation period when she began feeling itchy. Client denies shortness of breath, chest pain, nausea, no swelling or rash noted. PHN offered client Benadryl. Client accepted, per client, husband waiting in car and would drive client home. Vitals at 1806: blood pressure 144/99, pulse 76, oxygen sat 98%. PHN gave client Benadryl 50mg orally at 1806. Vitals at 1811: blood pressure 143/94, pulse 72, oxygen sat 98%. Client reports itchiness still present, no changes, lightheadedness resolved. No swelling or rash noted by RN . Vitals at 1816: blood pressure 143/98, pulse 73, oxygen sat 98%. Client reports itchiness same, mild rash noted on left forearm. Per client no shortness of breath or feeling of throat closing. Vitals at 1822: blood pressure 147/97, pulse 73, oxygen 98%. Client reports improvement of itchiness on forearms and chest. PHN  reviewed with client ER precautions and advised client to follow up with provider. Last vitals at 1837: blood pressure 136/94, pulse 77, oxygen sat 99%. Per client itchiness is just "mild at this time", rash on left forearm slightly visible, not spreading. Per client "feels fine to go home." Client completed 3o min observation, RN reviewed V-Safe information. Client left facility at 1839 with steady gait.
After receiving the vaccine we moved to waiting area.  Within minutes she told me she was not feeling well she began sweating profusely, her skin became pale and clammy, her eyes rolled back she lost consciousness and began convulsing.  She came to and said she could not hear well. She was taken to ED for observation and testing.
Mom states patient received her covid booster vaccine on 9/26/22.  The next day she had a low grade temperature and fatigue.  The next day (9/28/22) she reported to mom that she had chest pain.  Mom states she is unsure if the chest pains are continuous or if they come and go.  Patient complained again yesterday ( 10/4/22) to mom that she had chest pain and was gasping for air while at school.
Received the J&J vaccine in May 20. Started experiencing leg muscle and back pain June 1, 2021. Progressively got worse over the following weeks. On June 15 I woke up with a new pain in my leg. Went to urgent care and had a D-Dimer test that came out very high. I was sent to ER where they discovered one clot in each leg and two in my lungs via ultra sound and ct scan. I was immediately hooked up to herapin blood thinner through an IV. I was released the following afternoon with Eliquis blood thinner tablets.
Bilateral vision loss. Bilateral optic neuritis. Initially dx 6/25/14. Remissions and exacerbations until the present time. Improvement with steroids.
Moderna Covid-19 Vaccine was opened for more than 6 hours and it was administered to 7 patients; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 Vaccine was opened for more than 6 hours and it was administered to 7 patients) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 Vaccine was opened for more than 6 hours and it was administered to 7 patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 Vaccine was opened for more than 6 hours and it was administered to 7 patients) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment related informations were reported.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Follow-up received no newfurther information; Sender's Comments: This report refers to a case of Expired Product Administered for mRNA-1273 (Lot #: 030A21A)  with no associated AEs.
I got Covid after Dose 3 started experiencing congestion and diarrhea. About a week later I was treated for a cough and my symptoms lasted for a week.
The patient was admitted to the hospital on 4/25 c/o fatigue, hypoglycemia, and poor oral intake. He also complained of shortness of breath, which was an indication for a COVID-19 test. The specimen was collected and came back positive on 4/25. After a day at the hospital, the patient developed increased shortness of breath, had 80% oxygen saturation on a non-rebreather mask with subsequent upgrade to BiPap, and was using accessory muscles of respiration. His CXR on 4/25 on admission showed patchy b/l infiltrates. CT confirmed findings of CXR and was found to have ground glass opacities. The patient's ABG showed hypoxemia. On the morning of 4/27, the patient was found to be severely hypoxic and was electively intubated. As this form is being filled out, the patient is in the ICU on a ventilator due to COVID-19 pneumonia.
A later the day after the vaccine I was very fatigued and by the 3rd day I had chills so bad I was shaking.  I had a severe headache which felt worse than any migrane headache ever.  Body aches, fever of 100.4  and nausea which caused me to have to take off work.  I was tested for COVID-19 which was negative and I had a pounding HR as well which all symptoms pasted after about 2 1/2 days.
Employee received 1st HEP B vaccine on 3/12/21 as part of pre-employment process . She reported 1 month late that she felt weakness and pain 2 days post vaccine . However, she  insisted on getting 2nd HEP B vaccine on the affected L arm, despite education by staff to get vaccine on opposite arm. Patient now being treated with Naprosyn, Flexeril, and PT for pain and weakness.
I've had joint pain and swelling everyday starting the third week after my second dose.  This has never happened before.
I did not get my period for over 3 months; An odd bump in left ankle that would swell sometimes, that lasted about 3 months as well.; That area still hurts if I press on it but the bump feels much smaller.; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 07May2021(at the age of 45-years-old) as a single dose for COVID-19 immunisation. The medical history included hypothyroid but being treated with medication. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medication included levothyroxine sodium (LEVOTHYROXIN) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 16Apr2021(at the age of 45-years-old) as a single dose for COVID-19 immunisation. On 21May2021, after the second dose, the patient did not get her period for over three months. Although, the patient was in her forties, this had not happened to her before. Also, the patient formed an odd bump in her left ankle that would swell sometimes and had lasted about 3 months as well. That area still hurts if the patient pressed on it but the bump felt much smaller. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event did not get period for over 3 months was resolved on an unknown date in 2021, while the clinical outcome of the event odd bump in left ankle that would swell sometimes was resolving and the clinical outcome of the event that area still hurts if pressed on it was not resolved at the time of this report.
Joint pain in arms & shoulders.  Evaluated by Geneticist & Rheumatologist.
Information has been received from a pharmacist concerning a male patient who was vaccinated with a dose of ZOSTAVAX (Merck) (dose, expiration date and lot number not reported). On an unknown date the patient developed rash or possibly "shingles" after he received ZOSTAVAX (Merck). The patient called the pharmacy where he received the ZOSTAVAX (Merck) to report the incidence of rash. The patient did not complain of much pain associated with the rash. The pharmacist stated that the patient was not assessed by physician for definitive diagnosis of shingles. At the time of the report the outcome of the patient was unknown. Additional information has been requested.
did not feel well enough to go in for her second shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (did not feel well enough to go in for her second shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (did not feel well enough to go in for her second shot). At the time of the report, MALAISE (did not feel well enough to go in for her second shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported. The treatment information was unknown.
Pt recvd 3 doses of Engerix B in MAY 1991, June 1991, & Nov 21, 1991. 6 wks p/ the 3rd dose no antibodies were detected. Pt plans to receive additional doses.
No symptoms for 6 days. On 7th day arm discomfort and a large red area on upper left arm
My child missed her menstrual period.  She received her 2nd dose of Pfizer Covid-19 vaccination on 8/27/2021. She was expected to start her period on 9/9/21 and did not.  I took her to the doctor on 9/20/21.  The doctor was unsure why she didn't have a period. She also started her on birth control to help with heavy periods and acne.
Evening of the 2nd dose started having severe headaches.  Continued having severe headaches, fever, sharp internal pains moving from one organ to another throughout the night.  Next day severe headaches, fever,  internal pains, lethargy.  Difficulty thinking.
feeling hot; bad headache; aches muscles; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (feeling hot), HEADACHE (bad headache) and MYALGIA (aches muscles) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced FEELING HOT (feeling hot), HEADACHE (bad headache) and MYALGIA (aches muscles). At the time of the report, FEELING HOT (feeling hot), HEADACHE (bad headache) and MYALGIA (aches muscles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
mild self resolved wheezing for 30-45 min then diffuse urticaria, treated with Benadryl. Normal perfusion, nl exam without wheezing, stridor
Patient is complaining of arm soreness, tingling, and decrease of range of motion, and it has lasted for more than two weeks after receiving shot.
rash on center of back; headache; chills; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on center of back), HEADACHE (headache) and CHILLS (chills) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced RASH (rash on center of back), HEADACHE (headache) and CHILLS (chills). At the time of the report, RASH (rash on center of back), HEADACHE (headache) and CHILLS (chills) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported  No treatment information was provided    This case was linked to US-MODERNATX, INC.-MOD-2021-045351 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-045351:husband (male)
Joint pain on both legs which is also swollen and can not get up in the morning; Lower back pain; Left hand numbness; Joint pain on both legs which is also swollen and can not get up in the morning; This spontaneous case was reported by a consumer and describes the occurrence of JOINT SWELLING (Joint pain on both legs which is also swollen and can not get up in the morning), BACK PAIN (Lower back pain), HYPOAESTHESIA (Left hand numbness) and ARTHRALGIA (Joint pain on both legs which is also swollen and can not get up in the morning) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022C21A) for COVID-19 vaccination.     The patient's past medical history included Knee injury (she had injury back in 2009 on in her knees and fell down.) in 2009.    On 28-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced JOINT SWELLING (Joint pain on both legs which is also swollen and can not get up in the morning), BACK PAIN (Lower back pain), HYPOAESTHESIA (Left hand numbness) and ARTHRALGIA (Joint pain on both legs which is also swollen and can not get up in the morning). At the time of the report, JOINT SWELLING (Joint pain on both legs which is also swollen and can not get up in the morning), BACK PAIN (Lower back pain), HYPOAESTHESIA (Left hand numbness) and ARTHRALGIA (Joint pain on both legs which is also swollen and can not get up in the morning) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient had her last physical exam in August of 2021.  No Concomitant and Treatment medication were reported.
pt recv vax & exp itching @ the inj site which has cont for 1month; an ER or MD visit was required;
Three days after getting my vaccination my thyroid got enlarged and my TSH level became very low causing me to have hyperthyroid and my TSH level is just now getting back to normal. Went to the doctor 5 days after vaccination and was told to come back 2 months to get my levels check.
I woke up at 2AM on the  03/29/2021 with a severe headache, nausea and chills.  I went to get a RAPID test at CVS which was a NEG result.
Hives, Redness, and Itching from site of injection and down the left arm
Fever, chills, body aches began at 20:30 pm.  Fever and chills were done by morning.  Body aches continued throughout the next day.  I slept for 12 hours and on Tuesday morning, I was fine.
Minor -pain at injection site, pain in right wrist and  vision change which started about 3 hours after injection on Friday. Later in day I noticed a new dark circular floater.  Saw retinologist on Monday and learned I had a posterior vitreous detachment and Weiss ring.  Seems like more than a coincidence as I had no prior injury, my blood sugar is fairly well controlled, and I was well hydrated.
Shingles: Rash on scalp and nerve pain in ear and upper jaw; duration 6-weeks Antiviral medication (name unknown) and Gabapentin
Five year old received adult formulation of Pfizer 0.2ml drawn and administered by APRN
Lightheadedness, near syncope about 20 min after flu shot, while still in clinic. Similar symptoms in recent months independent of today's injection, may be unrelated.
I had to go to the Emergency room because I was 11 weeks pregnant and I was having abdominal pain. I was experiencing a miscarriage and it was my first pregnancy. While in the emergency room I was tested for COVID-19 and it was positive. I was not even having any symptoms and I never did really have any symptoms. I was hospitalized for 2 days due to the miscarriage but I never was sick from the COVID-19.
At moment of injection felt pain and heaviness in upper arm where given. Eyes watered. Had sharp pain in temporal area of head with headache remaining severe. Face flushed, sweating on forehead within 2-3 minutes. Left leg also tingling. Sent to ER. Motrin given for headache and released. AT ER 1hr 5 min.
Rash. (L) thigh erythema and redness. Eating, drinking ok.
After 10 min patient exhibited signs of syncope with loss of consciousness. Patient assisted in getting to floor and raised legs. Ambulance was called and vitals were good.
This case was reported by a physician via sales rep and described the occurrence of headache in a female patient who received SHINGRIX for prophylaxis. On 13th August 2018, the patient received the 2nd dose of SHINGRIX (intramuscular). In August 2018, less than a week after receiving SHINGRIX, the patient experienced headache, weakness, nausea and rash. The patient was treated with ibuprofen (Motrin) and benadryl (nos) (Benadryl). On an unknown date, the outcome of the headache, weakness, nausea and rash were recovered/resolved. The reporter considered the headache, weakness, nausea and rash to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received 1st dose of SHINGRIX which was asymptomatic. The patient came back to office on 15th August 2018, the patient complained of headache, weakness, nausea and scattered rash on both of her arms. The physician related these adverse events to SHINGRIX. The patient treated with Motrin and Benadryl and physician said that symptoms were resolved. The reporter agreed to be contacted for the follow up.
61 year old female client received her 1st done of Covid-19 Vaccine by Pfizer on her right arm via IM at 11:20 AM. At 11:25 AM client complained of tingling sensation on her lips.  Paramedics and MD on site arrive at the client at 11:28 AM, vitals are BP 168/90, HR 100, O2 98%, RR 17, Pain 0/10. MD gave patient water and educated patient proper breathing technique. At 11:35 AM client reported she feels so much better and she does not feel the tingling sensation on her lips anymore. Client was assisted to her car and was adviced to leave when she feels comfortable already.
Patient was hospitalized for complicated UTI/pyelonephritis, developed epigastric and chest pain while in hospital.
Passed out in the bathroom.  Hit face. Do not believe she was out very long.  Sustained a swollen and bruised right eye that eventually moved to the left.
Irregular heart beat after eating.   Food/beverage  sensitivities, like caffeine, wine,  carbonation.  Heartburn.